Inovio Pharmaceuticals
INO
#8851
Rank
NZ$0.25 B
Marketcap
NZ$3.73
Share price
-3.49%
Change (1 day)
17.70%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.94. In 2024 the company made an earnings per share (EPS) of NZ-$6.78 an increase over its 2023 EPS that were of NZ-$10.46.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.15%
2024NZ-$6.78-35.14%
2023NZ-$10.46-56.62%
2022NZ-$24.10-19.54%
2021NZ-$29.9635.9%
2020NZ-$22.04-11.57%
2019NZ-$24.9315.24%
2018NZ-$21.63-2.78%
2017NZ-$22.256.93%
2016NZ-$20.81134.88%
2015NZ-$8.86-29.51%
2014NZ-$12.57-57.34%
2013NZ-$29.46146.55%
2012NZ-$11.9520.83%
2011NZ-$9.89-29.41%
2010NZ-$14.01-48.48%
2009NZ-$27.1910%
2008NZ-$24.7211.11%
2007NZ-$22.25-41.3%
2006NZ-$37.91-66.91%
2005NZ-$114.54110.61%
2004NZ-$54.39-61.63%
2003NZ-$141.74186.67%
2002NZ-$49.44
2001N/A-100%
2000NZ-$39.56-63.64%
1999NZ-$108.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.95-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.92-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.15-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.64-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.04-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.17-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.19-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA